PAREXEL International

For over 30 years, PAREXEL has helped clients get their new and innovative drug treatments into the hands that need them most by simplifying their journey to market. Our global regulatory expertise, Phase I-IV clinical research services, integrated eClinical technologies, and advanced commercialization services all work together to move you through the development journey more smoothly and cost-effectively from beginning to end. PAREXEL has over 17,500 employees worldwide in 84 offices.